OS Therapies CEO on clinical advancements in immunotherapy for osteosarcoma
CEO & Founder Conversations
•
4m 43s
Paul Romness, CEO of OS Therapies, tells us about the company’s progress since its August 2024 IPO and its latest clinical advancements in immunotherapy for osteosarcoma and other solid tumors on #NYSEFloorTalk with Judy Shaw.
Up Next in CEO & Founder Conversations
-
Titan America CEO on driving innovati...
Bill Zarkalis, CEO and President of Titan America, a leading heavy building materials producer in the U.S., joined Judy Shaw on #NYSEFloorTalk to discuss how the company is driving innovation and sustainability in the industry.
-
iMotorbike CEO on transforming the mo...
Gil Carmo, Founder & CEO of iMotorBike, joined Judy Shaw on #NYSEFloorTalk to discuss how iMotorBike is transforming the motorcycle marketplace in Southeast Asia and creating a seamless experience for buyers and sellers. 🏍️
-
Clutch Security CEO on tackling cyber...
Ofir Har-Chen, Co-Founder & CEO of Clutch Security, shares how Clutch is tackling the growing cybersecurity risks of Non-Human Identities (NHIs) on #NYSEFloorTalk with Judy Shaw.
